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Abstract
Background: The plasma membrane scavenger receptor, SR-BI, mediates the 'selective uptake' process
by which cholesteryl esters (CE) from exogenously supplied HDL are taken up by target cells. Recent work
suggests that dimer and higher order oligomeric forms of the SR-BI protein are important to this process.
SR-BI has been shown to be particularly associated with microvilli and microvillar channels found at the
cell surface of steroidogenic cells, and a study with the hormone stimulated adrenal gland has shown
impressive changes in the size and complexity of the microvillar compartment as the mass of CE uptake
(and accompanying steroidogenesis) fluctuates. In the present study, we examine a cell line in which we
overexpress the SR-BI protein to determine if morphological, biochemical and functional events associated
with SR-BI in a controlled cell system are similar to those observed in the intact mammalian adrenal which
is responsive to systemic factors.
Methods: Y1-BS1 mouse adrenocortical cells were transiently transfected using rat SR-BI-pcDNA6-V5-
His, rat SR-BI-pcDNA6-cMyc-His or control pcDNA6-V5-His vector construct using a CaPO4
precipitation technique. Twenty four hours after transfection, cells were treated with, or without,
Bt2cAMP, and SR-BI expression, CE uptake, and steroidogenesis was measured. SR-BI dimerization and
cell surface architectural changes were assessed using immunoelectron microscopic techniques.
Results: Overexpression of the scavenger receptor protein, SR-BI, in Y1-BS1 cells results in major
alterations in cell surface architecture designed to increase uptake of HDL supplied-CEs. Changes include
[1] the formation of crater-like erosions of the surface with multiple double membraned channel
structures lining the craters, and [2] dimerized formations of SR-BI lining the newly formed craters and
associated double membraned channels.
Conclusion:  These data show that overexpression of the scavenger receptor protein, SR-BI
(accompanied by suitable hormone treatment and lipoproteins) in susceptible mammalian cells – is
associated with increased cholesterol uptake and SR-BI dimerization within a much enlarged and
architecturally complex microvillar compartment. These changes duplicate the structural, biochemical and
functional changes related to the uptake of HDL CEs normally signaled by the action of ACTH on intact
adrenal tissue.
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Background
The selective uptake of cholesteryl esters (CE) from lipo-
protein particles such as HDL is a process by which the
HDL core-CE is taken into cells without parallel uptake
and degradation of the HDL particle itself [1,2]. It repre-
sents a major route for the delivery of CEs to steroid pro-
ducing tissues of rodents and humans [3,4]. Scavenger
receptor, class B, type I (SR-BI), a member of the CD36
family of proteins [5], has been identified as an HDL
receptor that mediates the uptake of HDL-CEs via this
process [3-7], and immunochemical analyses indicate
that it is expressed most abundantly in steroidogenic cells
and liver [8-13]. Our published data provide evidence that
the physical state of the SR-BI protein (i.e., monomer, vs
dimeric and higher order oligomeric forms of SR-BI), and
architectural changes in the cell surface induced by the
expression of SR-BI, play major roles in the functional effi-
ciency of the selective pathway [14,15].
Tissues from the rat adrenal gland cortex illustrate these
findings particularly well [13]. The microvillar surface of
rat adrenal zona fasciculata cells show unusual flexibility
and responsiveness to hormonal simulation. In control
cells, the entire surface is covered by limp and disorgan-
ized appearing microvilli; occasionally the microvilli are
upright, occasionally they lie sideways, and every so often
the outer external plasma membrane of one microvillus
associates with an adjacent microvillus or other plasma
membrane surface forming a double membraned chan-
nel-like structure [13]. It is such channels where circulat-
ing lipoproteins (HDL and LDL) have been shown to be
trapped in vivo [16,17], and where even small VLDL can
often be found [18]. These formations are highly sensitive
to hormonal control in the rat adrenal. In ACTH or 17α-
E2 treatment of rats there is huge increase in the number
of adrenal fasciculata cell microvilli and microvillar chan-
nels and substantial architectural changes in the entire
microvillar compartment of these cells [13]. There is, as
well, a large increment in SR-BI content (adjusted for the
obvious increase in microvillar volume) associated with
this compartment, and there are corresponding increases
in selective HDL-CE uptake. In stark contrast, adrenal tis-
sue from animals in which dexamethasone has been used
to down regulate steroidogenesis shows a rapid decline in
all these features; as compared to cells from control ani-
mals, cortical cell microvilli from dexamethasone treated
animals are much reduced in number and complexity, few
microvillar channels can be found, SR-BI is virtually gone
from the compartment, and selective cholesterol uptake
of HDL-CE is barely measurable [13].
In subsequent studies we have shown that these various
SR-BI-related changes in the adrenal have a direct relation-
ship to SR-BI dimer formation; i.e., the level of SR-BI
dimerization (i.e. dimers + oligomers of a higher order)
appears invariably associated with the level of selective
HDL-CE uptake, SR-BI expression and changes in micro-
villar compartment architecture in the adrenals of treated
animals [14]. A similar relationship between SR-BI dimer-
ization and selective cholesterol uptake has been shown
also in cells from other steroidogenic tissues such as the
ovary and testis, as well as in a variety of cell lines [15].
In the current study, we set out to learn if the SR-BI related
changes observed in the adrenal gland could be repro-
duced in isolated cells grown in vitro; i.e., does overex-
pression of SR-BI in such cells lead directly to substantial
cell surface membrane changes? We chose as a cell model
a mouse adrenal tumor cell line (Y1-BS1 cells), which has
certain desirable characteristics: i.e., cells with modest
amounts of endogenous SR-BI, yet, like intact steroidog-
enic tissues, these cells have other essential cellular tools




Iodine-125I radionucleotide (carrier free, ~629 GBq/mg;
~17 Ci/mg) was purchased from PerkinElmer NEN® Radi-
onucleotides (Boston, MA). [1α, 2α (N)-3H] cholesteryl
oleolyl ether (1.78 TBq/mmol; 48.0 Ci/mmol) was
obtained from GE Health Care/Amersham Arlington
Heights, IL. 20α-Dihydroprogesterone, Bt2cAMP, leupe-
tin, PMSF, aprotinin and pepstatin A, goat anti-rabbit IgG-
horse-radish peroxidase (HRP) and rabbit-anti mouse
IgG-HRP were purchased from Sigma Chemical Co. (St.
Louis, MO). The LumiGLO Chemiluminescent Substrate
System used in Western blotting was obtained from KPL
(Gaithersburg, MD). Goat-anti-mouse IgG coupled to 10
nm colloidal gold and goat anti-rabbit IgG coupled to 15
nm colloidal gold were supplied by Ted Pella, Inc., (Read-
ing, CA). All other reagents used were of analytical grade.
Apo E-free high-density hHDL3 were isolated as described
previously [19]. For uptake and internalization studies,
hHDL3 preparations were conjugated with residualizing
labels, i.e., 125I-labeled dilactitol tyramine ([125I]DLT) and
[3H]cholesteryl oleolyl ether ([3H]COE) [20]
Cell culture and transient transfection
Y1-BS1, a sub-clone of Y1 mouse adrenocortical cells with
detectable levels of SR-BI [21] were obtained from Dr.
David Williams (SUNY at Stony Brook, NY) in 1998. The
cells are normally cultured in Ham's F10 medium supple-
mented with 15% equine serum, 2.5% fetal bovine serum
and 1% penicillin/streptomycin. For transient expression
experiments, Y1-BS1 cells were transfected with rat SR-BI-
pcDNA6-V5-His, rat SR-BI-pcDNA6-c-Myc-His or control
pcDNA6-V5-His vector construct using the CaPO4 precip-
itation technique [22]. Transfection efficiency was deter-
mined with β-galactosidase plasmid DNA to be about 10–Nutrition & Metabolism 2006, 3:43 http://www.nutritionandmetabolism.com/content/3/1/43
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15% in Y1-BS1 cells. For some studies, 24 h after transfec-
tion cells were treated with ± Bt2cAMP (2.5 mM) for 24 h.
All transfected cells were used for studies 48 h after trans-
fection.
Steroidogenic response
Cultures of Y1-BS1 cells were transfected with rSR-BI-V5-
pcDNA6.1 (or vector control) constructs for 48 h. Twenty
four hours after transfection, some cultures were treated
with Bt2cAMP (2.5 mM) for an additional 24 h. Subse-
quently, cells were incubated for 3–5 h in the absence
(basal) or presence of Bt2cAMP (2.5 mM) ± hHDL3 (500
μg protein/ml) as indicated. Following incubation, a suit-
able aliquot of the medium from each sample was col-
lected, and steroids were extracted from the medium using
methylene chloride and quantified by fluorescence in
65% sulfuric acid-35% ethanol using corticosterone as a
standard [23].
Immunoblot analysis
Washed transfected and non-transfected cells were lysed
in lysis buffer (125 mM Tris-HCl, pH 6.8, 2% SDS, 5%
glycerol, 1% 2-mercaptoethanol, 100 mM PMSF, 10 μg/
ml leupeptin, 20 μg/ml aprotinin, and 5 μg/ml pepstatin
A). After incubation at 37°C for 15 min, each lysate was
sonicated briefly to disrupt chromation (DNA) and then
used for immunoblotting.
Aliquots of cell lysates were mixed with equal volumes of
2X Laemmli sample buffer [20 mM Tris-HCl, PH 6.8, 2%
SDS (w/v), 10% sucrose (w/v), and 1% 2-mercaptoetha-
nol] and subjected to 7% SDS-PAGE [12]. For each sam-
ple, a constant amount of protein (10–40 μg) was loaded
on the gel. Protein standards (myosin, 200 kDa; β-galac-
tosidase, 116.3 kDa; phosphorylase b, 97.4 kDa; bovine
serum albumin (BSA) 66.2 kDa; and ovalbumin, 45 kDa)
were also loaded on the gel. After electrophoretic separa-
tion, the proteins were transferred to Immobilon® polyvi-
nyldene difluoride (PVDF) membranes using standard
techniques. The protein blots were incubated with either
polyclonal rabbit anti-SR-BI or monoclonal anti-V5 for 2
h at room temperature probed with peroxidase-labeled
anti-rabbit or anti-mouse IgG and visualized using the
LumiGLO Chemiluminescent Substrate System. The
resulting autographic chemiluminescence was visualized
for different time points (1–10 min), and appropriate
films were subjected to densitometric scanning.
Selective uptake of human HDL3-derived CEs
Cultures of Y1-BS1 cells were transfected with rSR-BI-V5-
pcDNA6.1 (or vector control) constructs for 48 h. Twenty
four hours after transfection, some cultures were treated
with Bt2cAMP (2.5 mM) for an additional 24 h at 37°C.
Cells were incubated with [125I] DLT- [3H] COE hHDL3
(100 μg/ml) for 5 h at 37°C. At the end of incubation, the
cells were processed to determine 125I-radioactivity, or
were extracted with organic solvents and the amounts of
CEs and apoproteins internalized via the endocytic and
selective pathways were computed [12,21]; results are
expressed as the net mass of CEs internalized.
ImmunoElectron microscopy
a) Single immunostaining technique: Y1-BS1 cells transiently
transfected with a SR-BI-V5 construct were incubated with
Bt2cAMP (2.5 mM) for the final 24 h. The cells were har-
vested, fixed as previously described [14,15], then stained
en bloc for 10 min with 0.75% tannic acid prior to
embedment in LRGold resin (Ted Pella). Ultrathin sec-
tions were immunostained using V5 mAb (40 μg protein/
ml) in 1% BSA for 2 h at room temperature followed by
secondary antibody staining with goat anti-mouse IgG
conjugated to 10 nm gold.
b) Double immunostaining technique: Cells were fixed and
processed as described above. Ultrathin sections were
blocked with 3% BSA and then incubated with a mixture
of V5-mAb (40 μg protein/ml) and cMyc-pAb (3 μg pro-
tein/ml) in 1% BSA for 2 h at room temperature. Note: to
reduce non-specific staining, the polyclonal antibody
(anti-cMyc) was pre-absorbed with 10% basal Y1-BS1 cell
homogenate. The secondary antibody was a mixture of
goat anti-mouse IgG conjugated to 10 nm gold (for V5
staining) and goat anti-rabbit IgG conjugated to 15 nm
gold (for cMyc staining).
c) dimer quantitation: SR-BI dimers were determined mor-
phologically by estimating the distance between two gold
particles considering the lengths of two primary and sec-
ondary immunoglobulin molecules and corrected for
possible molecule folding [13]. The estimated 'dimer'
length between 2 gold particles was calculated to be 2
times the width of a single cross sectional slice of plasma
membrane (thus two times the historically accepted value
of 100A), and judgment was made on high magnification
photographs (36 K × 3) where plasma membrane width
was clearly defined.
Results
Biochemical/physiological features of Y1-BS1 cells
Fig. 1 shows the Western blot expression of SR-BI in Y1-
BS1 mouse adrenocortical cells under basal conditions
and following incubation with Bt2cAMP for 24 h. Table 1
compares the steroidogenic response of Y1-BS1 cells
transiently transfected with empty vector or rat SR-BI and
treated with Bt2cAMP (2.5 mM) alone, or with hHDL3.
Whereas the steroidogenic response is similar following
hormone (cAMP) treatment of both the vector control
and the SR-BI transfected cells, the addition of hHDL3 to
the vector control cells induces a 2-fold increase in
response of the control cells and a 5 fold increase in theNutrition & Metabolism 2006, 3:43 http://www.nutritionandmetabolism.com/content/3/1/43
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transfected cells. It appears, therefore, that additional
stores of cholesterol are required for maximal hormone
production, and these stores can be supplied by exoge-
nously provided hHDL3. Table 2 shows that the net mass
of CE uptake is, in fact, 2 fold increased in hormone
treated Y1-BS1 cells transfected with SR-BI over control
(vector) transfected cells.
Due to the clear cut functional improvement in choles-
terol uptake and steroidogenesis following the use of both
HDL and cAMP in the SR-BI transfected cells, this treat-
ment was utilized in all subsequent morphological stud-
ies utlilizing this cell line.
Morphological features of control Y1-BS1 cells
Y1-BS1 cells cultured in a medium supplemented with
equine serum and fetal calf serum ± stimulation with
Bt2cAMP are healthy looking cells with a busy cytoplasm
and an active cell surface showing occasional patches of
microvilli, caveoli, coated vesicles, etc. No unusual cyto-
plasmic organelles or regions with unusual filamentous
activity are seen. Although aliquots of native (non-trans-
fected) Y1-BS1 cells contain substantial amounts of SR-BI
as measured by Western blotting (Fig. 1), individual cells
immunostained for SR-BI at the electron microscope level
show only light SR-BI staining. Treatment with B2cAMP in
these cells tends to increase surface microvilli and increase
SR-BI.
Morphological changes in Y1-BS1 cells transfected with 
SR-BI
Y1-BS1 cells are difficult to transfect and despite trials with
multiple reagents, transfection with the calcium phos-
phate precipitation technique was found to be the most
efficient. In all cases discussed, B2cAMP was used for 24 h
prior to cell collection which seemed to produce the most
dramatic results.
Fig. 2 shows adjacent surfaces of a non-transfected and a
double SR-BI construct transfected Y1-BS1 cell immunos-
tained with two SR-BI tags (V5 + cMyc). The non-trans-
fected cell surface shows abundant microvilli, but not one
immunogold particle (note: the antibodies used were not
for endogenous SR-BI, but specifically for the SR-BI V5 or
cMyc tags). In the transfected cell one sees an abnormal
appearing vesiculated surface with a high concentration of
both large gold (representing antibody to the cMyc tag)
plus small gold (representing antibody to the V5 tag) par-
ticles. The small gold particles represent staining with a
monoclonal antibody to V5 which is extraordinarily spe-
cific for the SR-BI-V5 tag. In contrast, the large gold repre-
sents a polyclonal antibody to cMyc which, in addition to
the tagged portion of the newly transfected SR-BI, may
stain other proteins in cells with close homologies to
cMyc. In the Y1-BS1 cells used in this study, mitochondria
are the prime targets for this non-SR-BI staining with
cMyc, and mitochondria from both control and trans-
fected cells in this study show occasional cMyc-gold stain-
ing.
Fig. 3A shows another surface version of an SR-BI trans-
fected Y1-BS1 cell, this time with a convoluted surface of
double membraned channels lightly stained for SR-BI-V5.
These undulating structures are similar to those observed
in adrenocortical cells of ACTH stimulated rats (see Fig.
3B); i.e., cells which express high levels of SR-BI, and
where the undulating double membraned channels con-
tain lipoprotein particles [13].
Fig. 4A is a low magnification photo of a section through
a highly expressing SR-BI-V5 transfected Y1-BS1 cell –
immunostained for the V5 antibody. It is clear that the
entire surface of the cell is altered. Whereas the majority of
the surface looks similar to the changes seen in the trans-
fected cell surface shown in Fig. 2, there are also complex
crater-like structures (see boxed areas) with their inner
surfaces composed of coiled double membraned channels
similar to those seen at the cell surfaces shown in Figs. 3A
and 3B. These craters can often be seen to open to the cell
surface, the center of the mass is gone, and just the coiled
double membrane lining structures remain. Only the sur-
face of the cell and the crater structures are immunogold
labeled for SR-BI-V5. One of these craters is shown at
higher magnification in Fig. 4B where the connection to
Western Blot analysis of SR-BI protein Figure 1
Western Blot analysis of SR-BI protein. Cell lysates 
were prepared from control and Bt2cAMP (2.5 mM)-treated 
Y1-BS1 adrenal cells. Suitable aliquots (10–40 μg protein) 
were subjected to SDS-PAGE followed by transfer of pro-
teins from gel to Immobiolon® membranes. The blots were 
incubated with rabbit anti-SR-BI and developed with an HRP-
based chemiluminescent detection system. Arrows indicate 
the position of SR-BI monomer and dimer/oligomers. The 
approximate molecular weights of top and bottom bands are 
160 kDa and 80 kDa, respectively.Nutrition & Metabolism 2006, 3:43 http://www.nutritionandmetabolism.com/content/3/1/43
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the surface is clear, and where it is certain that only the cra-
ter membranes (not the surrounding cytoplasm) is immu-
nostained for SR-BI. The double membraned channel
forming the continuous wall of this crater has coiled into
the surrounding cytoplasm enclosing areas of ordinary
cytoplasm including polysomes, coated vesicles and vacu-
oles.
In addition to surface disturbances, and double mem-
braned channel structure formation at the cell surface,
many SR-BI transfected cells also show areas deep within
the cells where immunogold staining reveals patches of
double membranes being formed; often such areas appear
at the edge of vacuoles (but occasionally there is no obvi-
ous connection with a cell structure). In Fig. 5, we show a
high magnification photo of such an area found quite
deep inside the cell, yet showing the wavy double mem-
braned channels and SR-BI immunostaining similar to
that found at the cell surface.
Surprisingly, in the SR-BI transfected Y1-BS1 cells
observed in this study, Golgi and endoplasmic reticulum
areas were stained only lightly, or not at all.
It is important to note that while all transfected Y1-BS1
cells showed a disrupted surface with a production of SR-
BI labeled double membraned channels, not all trans-
fected cells present the same level of change. It is not clear
whether the difference between cells reflects the fact that
some cells had more time (than other cells) to develop
advanced architectural changes, whether we are able to
view only a limited slice through any given transfected
cell, or whether certain cells are simply more resistant to
change than others.
Biochemical and morphological features of SR-BI dimer 
formation in SR-BI transfected Y1-BS1 cells
A previous biochemical study from this laboratory identi-
fied significant levels of SR-BI monomers in native Y1-BS1
Table 2: Selective HDL-CE uptake by control Y1-BS1 cells and cells transiently overexpressing SR-BI.
Experimental Conditions Mass of selective HDL-CE uptake (ng CE/mg cell protein/5h ± SE)
Control (vector) transfected cells
• Basal 607 ± 128
• Bt2cAMP (2.5 mM) 1802 ± 463a
SR-BI transfected cells
• Basal 1623 ± 295b
• Bt2cAMP (2.5 mM) 3514 ± 48c,d
Results are Mean ± SE of four separate experiments.
Y1-BS1 mouse adrenocortical cells were transfected with rSR-BI-V5-pcDNA6.1 construct (or control vector) for 48 h. Twenty four hours after 
transfection, some cultures were treated with Bt2cAMP (2.5 mM) for an additional 24 h. Subsequently, cells were incubated with radiolabeled, non-
releasable apolipoprotein ([125I] DLT) and cholesteryl ester ([3H] COE) tags ± Bt2AMP (2.5 mM) that would accumulate within cells. Uptake by the 
selective pathway was determined as described under Experimental Procedures.
ap = 0.0471 vs basal control transfected cells; bp = 0.0196 vs basal control transfected cells; cp = 0.0159 vs basal SR-BI transfected cells; dp = 0.0434 
vs Bt2cAMP-treated control transfected cells.
Table 1: Steroid production by control (non-transfected) and SR-BI transfected Y1-BS1 mouse adrenocortical cells
Experimental Conditions 20α-Dihydroprogesterone (ng/mg cell protein/5h ± SE)
Control (vector)-transfected Y1-BS1 Cells
• Bt2cAMP (2.5 mM) 4542 ± 990
• Bt2cAMP + hHDL3 11620 ± 2041
SR-BI transfected Y1-BS1 cells
• Bt2cAMP (2.5 mM) 5303 ± 1298
• Bt2cAMP + hHDL3 26340 ± 2059¶
Results are Mean ± SE of four separate experiments.
Cultures of Y1-BS1 cells were transfected with rSR-BI-V5-pcDNA6.1 (or vector control) constructs for 48 h. Twenty four hours after transfection, 
some cultures were treated with Bt2cAMP (2.5 mM) for an additional 24 h. Subsequently, cells were incubated for 5 h in the absence (basal) or 
presence of Bt2cAMP (2.5 mM) ± hHDL3 (500 μg protein/ml) as indicated. Following incubation, a suitable aliquot of the medium from each sample 
was collected, and steroids were extracted from the medium using methylene chloride and quantified by fluorescence in 65% sulfuric acid-35% 
ethanol using corticosterone as a standard.
¶ p = 0.0023 vs Bt2cAMP + hHDL3-treated control cellsNutrition & Metabolism 2006, 3:43 http://www.nutritionandmetabolism.com/content/3/1/43
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cells, with an increased concentration of monomer SR-BI
and some dimer SR-BI expression in cells treated with
Bt2cAMP [14]. Whereas, the SR-BI monomers are ~3 fold
increased in the SR-BI transfected cells, SR-BI dimer/oli-
gomer forms are found in substantially higher propor-
tions relative to their monomer forms in the transfected
cells, and are especially high in those cells treated with
cAMP (data not shown) – the same category of cells which
show increased steroidogenic capacity and selective cho-
lesterol uptake function in table 2 above.
In the high magnification micrograph of Fig. 6, we see
another example of the cell surface double membraned
craters described earlier in Fig. 4. In Fig. 6, however, the
cell was co-transfected with SR-BI V5 (small gold) + SR-BI
cMyc (large gold), and immunostained with monoclonal
and polyclonal antibodies to the two tags as shown with
different sized gold particles. The co-transfection in this
case permits identifying SR-BI dimer formation morpho-
logically, and provides the possibility of quantification of
dimer and oligomer forms as shown in Table 3. Despite
corrective measures, there is always concern about ran-
dom gold clustering in solutions, and, in our effort to
quantitate dimers, the possibility exists that closely associ-
ated gold particles may not necessarily represent true
dimer formations. As shown in Fig. 6, it is possible to get
around this issue by considering 3 possible types of
closely associated gold particles (as defined in the Meth-
ods section): 2 closely associated large gold particles, 2
small  gold particles, but also, closely associated large +
small gold particles. In Fig. 6, and in other similar areas of
SR-BI stained double membranes used to quantify dimer
formation morphologically (Table 3), it is clear that the
relative numbers of large + small gold combinations is
substantial, and also similar in number to the other pos-
sible dimer combinations. This is a reality check: large/
small gold dimer combinations indicate that antibodies
for two entirely different proteins V5 and cMyc are not
only present at the same cell site, but in close enough asso-
ciation to form numerous dimer formations when stained
with their respective secondary antibodies tagged with dif-
ferent sized gold particles. Table 3 shows the results of
quantifying SR-BI dimer combinations from cell surface
related areas of SR-BI immunogold found in co-trans-
fected cells, and indicates that when all the possible dimer
formations are considered together, more than 40% of the
gold found in these areas represents sites of SR-BI dimeri-
zation. SR-BI staining of regions with double membrane
formations found inside transfected cells (as described in
Fig. 5), also show substantial dimerization of SR-BI.
Discussion
This study clearly shows that transfection of Y1-BS1 cells
(a mouse adrenal cell line) with rat SR-BI using a calcium
phosphate precipitation technique results in cells with a
dramatically altered cell surface. One version of this dis-
rupted surface can be described as an explosion of SR-BI
stained vesicles -where the original plasma membrane
(including caveoli, clathrin coated pits, typical microvillar
structures) no longer exists, but appears to have become
part of the vesicular mass. However, in most of the trans-
fected cells one also sees the development of multiple and
Photo shows typical surfaces of SR-BI transfected (TF) and  non transfected (non-TF) Y1-BS1 cells Figure 2
Photo shows typical surfaces of SR-BI transfected 
(TF) and non transfected (non-TF) Y1-BS1 cells. The 
non-TF cell has a smooth surface, patches of long, slender 
microvilli, and shows no surface colloidal gold particle repre-
senting SR-BI-V5 or -cMyc staining. In contrast, the TF cell 
has a disrupted surface consisting of vesicles and small vacu-
oles which are stained with a mixture of gold particles repre-
senting V5 staining (small gold) and cMyc staining (large gold). 
The small boxes identify potential V5/cMyc dimers, where 
small and large gold particles are in very close contact.Nutrition & Metabolism 2006, 3:43 http://www.nutritionandmetabolism.com/content/3/1/43
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A – Illustration of another surface membrane pattern of an SR-BI-V5 transfected Y1-BS1 cell revealing undulating double mem- braned channels (arrowheads) Figure 3
A – Illustration of another surface membrane pattern of an SR-BI-V5 transfected Y1-BS1 cell revealing undu-
lating double membraned channels (arrowheads). Such channel membranes are open to the cell surface (arrow) and dip 
into the cell where they encircle patches of cytoplasm. B – The surface of a cortical cell from the adrenal of an ACTH 
treated rat processed by standard (non-immunochemical) procedures [13]. The surface of this cell illustrates the 
similarity between the double membraned surface structures of normal hormone-stimulated adrenocortical cells with those 
formed in SR-BI transfected cells -as shown in Fig. 3A. Note, that in this normal adrenal cell, the double membraned channels 
also open to the cell surface (arrows). Striations within the channels (arrowheads) identify lipoproteins [13].
A.
B.Nutrition & Metabolism 2006, 3:43 http://www.nutritionandmetabolism.com/content/3/1/43
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A – Low magnification photo of a section through a highly expressing SR-BI-V5 transfected Y1-BS1 cell immunostained for the  V5 tag Figure 4
A – Low magnification photo of a section through a highly expressing SR-BI-V5 transfected Y1-BS1 cell immu-
nostained for the V5 tag. In addition to the totally disrupted cell surface, note the two complicated crater-like structures 
(see boxed areas) lined with convoluted double membrane channel structures. B – A higher magnification photo of the 
larger crater seen in figure 4A. Note the center of the mass is gone and just the coiled double membranes (arrows) repre-
senting the wall of the crater remain. One loop of coiled membrane opens to the cell surface (asterisk). The gold particles, rep-
resenting SR-BI-V5 staining, are associated with vesicles and membranes of the crater structure.
A.
B.Nutrition & Metabolism 2006, 3:43 http://www.nutritionandmetabolism.com/content/3/1/43
Page 9 of 11
(page number not for citation purposes)
quite elaborate SR-BI stained double membraned channel
structures at the cell surface, which in their width, their
intertwining curving nature, and their general architecture
resemble the complex double membraned structures seen
associated with the microvillar compartment of hormone-
stimulated adrenocortical or ovarian cells in tissues of the
normal rat. It is clear that the morphological plasma
membrane changes we see are always associated with SR-
BI (as they are in intact sections of steroidogenic tissue),
and in the case of the Y1-BS1 cell preparations, only cells
showing accumulations of SR-BI, show any of the physical
changes noted.
In addition to these cell surface related changes, SR-BI
transfected cells may also show accumulations of SR-BI
intracellularly, often associated with non-identifiable vac-
uoles or masses found deep within the cell. Along the
edges of these masses, patches of SR-BI accumulation can
occasionally be identified, and, no matter how big or
small the SR-BI mass, it is always associated with double
membraned structures – some circular, some long, but in
every way identical morphologically to the double mem-
Table 3: Immunogold Dimer Formation Associated with SR-BI-enriched Cell Surface Sites of SR-BI-V5 + SR-BI-cMyc Transfected Y1-
BS1 Cells
Expt. no. Total gold in 
region measured
Large + small 
heterodimer
Small + small 
homodimer
Large + large 
homodimer
Total dimers Total* dimer 
gold
Dimer gold as 
percent of total gold
1 615 42 33 46 121 242 39%
2 1513 99 94 99 292 584 39%
3 756 53 85 32 170 340 45%
*Note: Since each dimer represents two gold particles, "total dimer gold" represents total dimers X 2. This number divided by the "total gold in the 
region" represents the percentage of total gold found as dimers.
Small 10 nm gold coupled to anti-mouse-IgG was used to identify V5 monoclonal antibody staining of the Y1-BS1 cells transfected with an SR- B1-
V5 tag cDNA construct.
Large, 15 nm gold complexed with anti-rabbit IgG was used to identify cMyc polyclonal antibody staining of the Y1-BS1 transfected SR-BI-cMyc tag 
plasmid DNA. Close contact between gold particles was used to identify the 3 possible dimer combinations, and, as shown here, the numbers were 
similar (indicating reasonable levels of first and second antibody concentrations had been used to balance differences in antibody sensitivities and 
size of gold particles).
Large/small gold dimer combinations indicate that secondary antibodies representing anti-mouse IgG gold (V5 staining) and anti-rabbit IgG gold 
(cMyc staining) are present at the same cell site, and, as such, eliminate the possibility that random gold clustering in solution is responsible for the 
dimer-like formations.
Heavily immunostained surface crater-like formation with  undulating double membranes in a cell co-transfected with  SR-BI-V5 and SR-BI-cMyc constructs Figure 6
Heavily immunostained surface crater-like formation 
with undulating double membranes in a cell co-trans-
fected with SR-BI-V5 and SR-BI-cMyc constructs. 
Note: the numerous closely associated gold particles repre-
senting dimers of cMyc (large gold), V5 (small gold) and the 
combination of cMyc + V5 (see circles) with large+small gold.
This figure shows a region with coiled double membranes  (arrowheads) found deep within a cell which had been co- transfected with SR-BI-V5 and SR-BI-cMyc cDNA plasmids Figure 5
This figure shows a region with coiled double mem-
branes (arrowheads) found deep within a cell which 
had been co-transfected with SR-BI-V5 and SR-BI-
cMyc cDNA plasmids. Such sites showing double mem-
braned structures associated with SR-BI constructs are often 
seen at the edge of vacuoles within the cytoplasm.Nutrition & Metabolism 2006, 3:43 http://www.nutritionandmetabolism.com/content/3/1/43
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braned channel structures associated with the cell surface.
While it is possible that these intracellularly located struc-
tures are, in fact, connected to the cell surface (at a point
not visible in our sections), it seems possible that these
deep sites are where SR-BI has accumulated, but has not
been appropriately transported to the cell surface. Per-
haps, in such cells, the production of SR-BI is so large that
transport and utilization of the protein at the surface does
not have sufficient time (or sufficient delivery proteins or
equipment) to occur. And, like in SF9 insect cells infected
with SR-BII (Reaven & Azhar, unpublished observations),
the stalled delivery system deposits the protein at some
site, and with the help of available cell machinery, the
double membraned channels meant for the surface are
actually produced in situ.
How SR-BI is transported through the cell is not yet clear.
The multiple glycosylation sites of SR-BI [19] strongly sug-
gest that the nascent protein must pass through trans
Golgi membranes, but remarkably little SR-BI is visible in,
or around, the Golgi areas, despite the use of multiple
antibody types (anti SR-BI against the C-terminal or extra-
cellular domain (ECD) or V5 or cMYc tagged SR-BI).
Indeed, the most heavily transfected cells do not seem to
have easily identifiable Golgi areas at all, and one won-
ders if transport of the newly formed protein has
exhausted the Golgi membranes-which then are distrib-
uted throughout the cell and perhaps form the basis for
some of the intracellular sites of SR-BI which we do see.
Likewise, the existing endoplasmic reticulum is not heav-
ily labeled for SR-BI, though in occasional cells one can
find patches of wavy ER-like membranes (some even with
attached ribosomes) which appear to stain lightly for SR-
BI. Perhaps passage of the nascent protein through these
traditional membranes is too rapid a process to show up
dramatically. Or, as is always possible, the antigenic sites
of SR-BI may be masked at these early stages, and it is not
until the protein later dimerizes in situ, or at the cell sur-
face, that the protein becomes available for immunostain-
ing.
What remains clear is that cellular sites where SR-BI is
prominent (e.g. surface membrane + surface or intracellu-
lar craters) show a high degree of SR-BI dimerization.
Approximately 40% of the gold particles found in such
areas are in close contact with each other, and this remains
true whether the immuno-gold represents staining of two
SR-BI V5 molecules, two SR-BI cMyc molecules, or a com-
bination of the two different tags (therefore a dimer com-
posed of SR-BI-V5+SR-BI cMyc). Indeed, the double
tagged dimer re-enforces the idea that SR-BI, whatever its
identification tag, migrates to the same cell region, and is
intimately involved in the construction of the double
membraned channels which result.
Finally, to what extent do the attributes of an exquisitely
complex cell surface of double membraned channels
composed of highly dimerized molecules of SR-BI lead to
heightened cell function? We suggest that cells with coils
of double membraned channels containing dimerized SR-
BI are capable of taking up vast numbers of HDL particles
[13,14] in any given preparation. Such cells with their
substantially increased cell surface and heightened ability
to attract and trap HDL will also deliver increased CE mass
to the cell interior as substrate for increased steroid pro-
duction.
Conclusion
These data indicate that overexpression of the scavenger
receptor protein, SR-BI, in a receptive mouse adrenocorti-
cal tumor cell line (Y1-BS1) leads to a complex cell surface
of double membraned channels endowed with highly
dimerized molecules of SR-BI. As a result, this hormone-
stimulated adrenal tumor cell overexpressing SR-BI, like
cells of the ACTH stimulated rat adrenal, is capable of cap-
turing increased numbers of HDL, internalizing increased
amounts of cholesteryl esters and secreting increased lev-
els of steroid hormone.
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